Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue

Aliment Pharmacol Ther. 2020 Sep;52(5):889-890. doi: 10.1111/apt.15965.

Authors

Sung Won Lee^{1

2}, Seung Up Kim^{3

4}

Affiliations

¹ Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
² The Catholic University Liver Research Center, Seoul, Korea.
³ Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
⁴ Yonsei Liver Center, Severance Hospital, Seoul, Korea.

PMID: 32852818
DOI: 10.1111/apt.15965

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents* / therapeutic use
Guanine / analogs & derivatives
Hepatitis B virus
Hepatitis B, Chronic* / drug therapy
Humans
Retrospective Studies
Tenofovir / therapeutic use

Substances

Antiviral Agents
entecavir
Guanine
Tenofovir